Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines
Endocrinology and Metabolism · 29.02.2024 · 39 (1) · 47-60
DOI: 10.3803/enm.2024.1937 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 29.02.2024. Verfasst von Min Joo Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroidectomy. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
The indolent nature and favorable outcomes associated with papillary thyroid microcarcinoma have prompted numerous prospective studies on active surveillance (AS) and its adoption as an alternative to immediate surgery in managing low-risk thyroid cancer. This article reviews the current status of AS, as outlined in various international practice guidelines. AS is typically recommended for tumors that measure 1 cm or less in diameter and do not exhibit aggressive subtypes on cytology, extrathyroidal extension, lymph node metastasis, or distant metastasis. To determine the most appropriate candidates for AS, factors such as tumor size, location, multiplicity, and ultrasound findings are considered, along with patient characteristics like medical condition, age, and family history. Moreover, shared decision-making, which includes patient-reported outcomes such as quality of life and cost-effectiveness, is essential. During AS, patients undergo regular ultrasound examinations to monitor for signs of disease progression, including tumor growth, extrathyroidal extension, or lymph node metastasis. In conclusion, while AS is a feasible and reliable approach for managing lowrisk thyroid cancer, it requires careful patient selection, effective communication for shared decision-making, standardized follow-up protocols, and a clear definition of disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, National Cancer Center, Goyang, Korea.
- Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
- Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Korea.
- Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Förderung
- Ministry of Health and Welfare
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Kim, M. J., Moon, J. H., Lee, E. K., Song, Y. S., Jung, K. Y., Lee, J. Y., Kim, J. H., Kim, K., Park, S. K., & Park, Y. J. (2024). Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines. Endocrinology and Metabolism, 39(1), 47-60. https://doi.org/10.3803/enm.2024.1937
Vancouver
Kim MJ, Moon JH, Lee EK, Song YS, Jung KY, Lee JY, et al. Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines. Endocrinology and Metabolism. 2024;39(1):47-60. doi:10.3803/enm.2024.1937
BibTeX
@article{Kim2024,
author = {Kim, Min Joo and Moon, Jae Hoon and Lee, Eun Kyung and Song, Young Shin and Jung, Kyong Yeun and Lee, Ji Ye and Kim, Ji-Hoon and Kim, Kyungsik and Park, Sue K and Park, Young Joo},
title = {Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines},
journal = {Endocrinology and Metabolism},
year = {2024},
volume = {39},
number = {1},
pages = {47--60},
doi = {10.3803/enm.2024.1937}
}
EUVIMED